Multicenter Phase II Trial (SWOG S1609, Cohort 51) of Ipilimumab and Nivolumab in Metastatic or Unresectable Angiosarcoma: a Substudy of Dual Anti-Ctla-4 and Anti-Pd-1 Blockade in Rare Tumors (DART)
Journal for ImmunoTherapy of Cancer（2021）
关键词
Sarcoma,Clinical Trials,Phase II as Topic,Drug Therapy,Combination,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要